Cargando…

Defining new criteria for selection of cell-based intestinal models using publicly available databases

BACKGROUND: The criteria for choosing relevant cell lines among a vast panel of available intestinal-derived lines exhibiting a wide range of functional properties are still ill-defined. The objective of this study was, therefore, to establish objective criteria for choosing relevant cell lines to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Jon, El-Gebali, Sara, Natoli, Manuela, Sengstag, Thierry, Delorenzi, Mauro, Bentz, Susanne, Bouzourene, Hanifa, Rumbo, Martin, Felsani, Armando, Siissalo, Sanna, Hirvonen, Jouni, Vila, Maya R, Saletti, Piercarlo, Aguet, Michel, Anderle, Pascale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412164/
https://www.ncbi.nlm.nih.gov/pubmed/22726358
http://dx.doi.org/10.1186/1471-2164-13-274
_version_ 1782239929320865792
author Christensen, Jon
El-Gebali, Sara
Natoli, Manuela
Sengstag, Thierry
Delorenzi, Mauro
Bentz, Susanne
Bouzourene, Hanifa
Rumbo, Martin
Felsani, Armando
Siissalo, Sanna
Hirvonen, Jouni
Vila, Maya R
Saletti, Piercarlo
Aguet, Michel
Anderle, Pascale
author_facet Christensen, Jon
El-Gebali, Sara
Natoli, Manuela
Sengstag, Thierry
Delorenzi, Mauro
Bentz, Susanne
Bouzourene, Hanifa
Rumbo, Martin
Felsani, Armando
Siissalo, Sanna
Hirvonen, Jouni
Vila, Maya R
Saletti, Piercarlo
Aguet, Michel
Anderle, Pascale
author_sort Christensen, Jon
collection PubMed
description BACKGROUND: The criteria for choosing relevant cell lines among a vast panel of available intestinal-derived lines exhibiting a wide range of functional properties are still ill-defined. The objective of this study was, therefore, to establish objective criteria for choosing relevant cell lines to assess their appropriateness as tumor models as well as for drug absorption studies. RESULTS: We made use of publicly available expression signatures and cell based functional assays to delineate differences between various intestinal colon carcinoma cell lines and normal intestinal epithelium. We have compared a panel of intestinal cell lines with patient-derived normal and tumor epithelium and classified them according to traits relating to oncogenic pathway activity, epithelial-mesenchymal transition (EMT) and stemness, migratory properties, proliferative activity, transporter expression profiles and chemosensitivity. For example, SW480 represent an EMT-high, migratory phenotype and scored highest in terms of signatures associated to worse overall survival and higher risk of recurrence based on patient derived databases. On the other hand, differentiated HT29 and T84 cells showed gene expression patterns closest to tumor bulk derived cells. Regarding drug absorption, we confirmed that differentiated Caco-2 cells are the model of choice for active uptake studies in the small intestine. Regarding chemosensitivity we were unable to confirm a recently proposed association of chemo-resistance with EMT traits. However, a novel signature was identified through mining of NCI60 GI50 values that allowed to rank the panel of intestinal cell lines according to their drug responsiveness to commonly used chemotherapeutics. CONCLUSIONS: This study presents a straightforward strategy to exploit publicly available gene expression data to guide the choice of cell-based models. While this approach does not overcome the major limitations of such models, introducing a rank order of selected features may allow selecting model cell lines that are more adapted and pertinent to the addressed biological question.
format Online
Article
Text
id pubmed-3412164
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34121642012-08-06 Defining new criteria for selection of cell-based intestinal models using publicly available databases Christensen, Jon El-Gebali, Sara Natoli, Manuela Sengstag, Thierry Delorenzi, Mauro Bentz, Susanne Bouzourene, Hanifa Rumbo, Martin Felsani, Armando Siissalo, Sanna Hirvonen, Jouni Vila, Maya R Saletti, Piercarlo Aguet, Michel Anderle, Pascale BMC Genomics Research Article BACKGROUND: The criteria for choosing relevant cell lines among a vast panel of available intestinal-derived lines exhibiting a wide range of functional properties are still ill-defined. The objective of this study was, therefore, to establish objective criteria for choosing relevant cell lines to assess their appropriateness as tumor models as well as for drug absorption studies. RESULTS: We made use of publicly available expression signatures and cell based functional assays to delineate differences between various intestinal colon carcinoma cell lines and normal intestinal epithelium. We have compared a panel of intestinal cell lines with patient-derived normal and tumor epithelium and classified them according to traits relating to oncogenic pathway activity, epithelial-mesenchymal transition (EMT) and stemness, migratory properties, proliferative activity, transporter expression profiles and chemosensitivity. For example, SW480 represent an EMT-high, migratory phenotype and scored highest in terms of signatures associated to worse overall survival and higher risk of recurrence based on patient derived databases. On the other hand, differentiated HT29 and T84 cells showed gene expression patterns closest to tumor bulk derived cells. Regarding drug absorption, we confirmed that differentiated Caco-2 cells are the model of choice for active uptake studies in the small intestine. Regarding chemosensitivity we were unable to confirm a recently proposed association of chemo-resistance with EMT traits. However, a novel signature was identified through mining of NCI60 GI50 values that allowed to rank the panel of intestinal cell lines according to their drug responsiveness to commonly used chemotherapeutics. CONCLUSIONS: This study presents a straightforward strategy to exploit publicly available gene expression data to guide the choice of cell-based models. While this approach does not overcome the major limitations of such models, introducing a rank order of selected features may allow selecting model cell lines that are more adapted and pertinent to the addressed biological question. BioMed Central 2012-06-22 /pmc/articles/PMC3412164/ /pubmed/22726358 http://dx.doi.org/10.1186/1471-2164-13-274 Text en Copyright ©2012 Christensen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Christensen, Jon
El-Gebali, Sara
Natoli, Manuela
Sengstag, Thierry
Delorenzi, Mauro
Bentz, Susanne
Bouzourene, Hanifa
Rumbo, Martin
Felsani, Armando
Siissalo, Sanna
Hirvonen, Jouni
Vila, Maya R
Saletti, Piercarlo
Aguet, Michel
Anderle, Pascale
Defining new criteria for selection of cell-based intestinal models using publicly available databases
title Defining new criteria for selection of cell-based intestinal models using publicly available databases
title_full Defining new criteria for selection of cell-based intestinal models using publicly available databases
title_fullStr Defining new criteria for selection of cell-based intestinal models using publicly available databases
title_full_unstemmed Defining new criteria for selection of cell-based intestinal models using publicly available databases
title_short Defining new criteria for selection of cell-based intestinal models using publicly available databases
title_sort defining new criteria for selection of cell-based intestinal models using publicly available databases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412164/
https://www.ncbi.nlm.nih.gov/pubmed/22726358
http://dx.doi.org/10.1186/1471-2164-13-274
work_keys_str_mv AT christensenjon definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases
AT elgebalisara definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases
AT natolimanuela definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases
AT sengstagthierry definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases
AT delorenzimauro definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases
AT bentzsusanne definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases
AT bouzourenehanifa definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases
AT rumbomartin definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases
AT felsaniarmando definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases
AT siissalosanna definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases
AT hirvonenjouni definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases
AT vilamayar definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases
AT salettipiercarlo definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases
AT aguetmichel definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases
AT anderlepascale definingnewcriteriaforselectionofcellbasedintestinalmodelsusingpubliclyavailabledatabases